With the support of WILD as a serial production partner, LUMA Vision is bringing the first catheter-based 4D imaging system to the market that offers real-time imagery of the beating heart thanks to an innovative navigation platform.

Atrial fibrillation, the most common form of cardiac arrhythmia worldwide, significantly increases the risk of stroke and heart failure. Treatment of this disorder is complex and puts a great burden on those  affected. With VERAFEYE™, German-Irish medical technology company LUMA Vision is about to revolutionise the treatment of cardiac arrhythmias. The novelty here is that, contrary to conventional systems which mostly deliver two-dimensional or, at best, three-dimensional images, VERAFEYE™ features a 4D navigation and imaging platform that displays the heart in motion. As a result, physicians can carry out interventions with much greater certainty.

DYNAMIC VISUALISATION MEANS GREATER PRECISION
For this purpose, LUMA Vision uses a proprietary catheter sensor in combination with advanced imaging to deliver 360-degree images of the beating heart and its surrounding anatomy in real time. Artificial intelligence simultaneously analyses all this image data and automatically  identifies relevant structures, thus supporting cardiologists in their assessment of the tissue. This facilitates instrument control, reduces intervention times and increases patient safety.

The end-to-end system is unique in clinical application to date. A true innovation with a startup behind it, one that deliberately took the WILD Group on board for the transition to serial production and the subsequent stable manufacturing of the device. ”As a young team, it is important for us to receive honest feedback on our product and its demanding manufacturing from an experienced technology partner“, stresses Torsten Scheuermann, Director Advanced Projects at LUMA Vision. ”We were won over by WILD‘s references and its longstanding experience in optics, signal processing, robotics, mechatronics and precision mechanics. In addition, they work on the basis of validated processes and they guarantee a stable product quality. The close coordination and open communication also help create transparency and trust – two essential factors for us as a young company with limited resources.“

The WILD Group is currently supporting the transition to serial production and will ultimately take over serial manufacturing as well. In addition to assembly and mechanical manufacturing, there will be a particular focus on building up a resilient supply chain for over 400 individual parts. ”We feel that we are in very good hands and we communicate on a daily basis to achieve the ambitious timelines for the production transfer“, Scheuermann explains. The first systems are scheduled to roll off the line within 2025. ”We are planning a lot of things in the coming years and WILD will have a very important role to play.“